Email Us Here

SignaBlok to Highlight SCHOOL Therapeutic Peptides at the 2015 Essential Protein Engineering Summit

Preclinical studies of novel peptide inhibitors (SCHOOL peptides) will be presented in an oral session. Presentation will highlight company's approach to targeted peptide delivery and support development of programs in oncology, sepsis and arthritis.